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Considerations for lmmunocontraception Among
Free.Ranging Carnivores: The Rabies Paradigm
Cathleen A. Hanlon and Charles E. Rupprecht

The raging North American controversy over the
reintroduction of wolves into the ecosystem of the
greater Yellowstone National Park area exemplifies
the emotive relationship between humankind and the
Carnivora. What forces act in concert to portray this
much maligned Order in unfavorable light? Control of
free-ranging carnivore populations by Homo sapiens
has been practiced for centuries as part of a pastoral
lifestyle, with the intent of protecting one's own life and
livelihood from becoming freshly killed prey in the
onslaught from mammalian competitors. Traditionally,
control is equated most commonly with population
reduction through direct elimination of individuals
(e.g., typically social canids or solitary large-bodied
felids) via lethal means including shooting, poisoning,
trapping, gassing of dens, and habitat modification
(Lewis 1968, U.S. Department of Agriculture 1992).
In addition to reducing direct predation upon domestic
livestock (sheep and cattle losses alone in the United
States are estimated in excess of $80,000,000 annually [U.S. Department of Agriculture, National Agricultural Statistics Service 1991j), other perceived
beneficial aspects of free-ranging carnivore population
reduction include conservation of endangered species,
such as Australian marsupials, subject to predation by
introduced European red foxes (Boyle 1994), conservation of otherwise "desirable" species (game fowl and
wild ungulates), and the alleviation of objectionable
human-carnivore interactions (Wynne-Edwards
1964). Today, such interactions range from local
citizen complaints of seemingly frivolous or nuisance
wildlife encounter-raccoon disruption of a backyard
songbird feeder, bear vandalism at vacation homes,
etc.-to significant global public health issues (such
as animal bite from the stray dog) and related human
mortality either directly from overt injury or indirectly
from exposure to a plethora of zoonoses, such as
rabies or echinococcosis (Beran 1994). Nevertheless, a "manageable" number of mammalian carnivores is clearly viewed as beneficial when they serve
human desire for sport, pelts, companionship, etc.
Moreover, sound ecological, economic, and ethical
arguments weigh against sole reliance upon lethal
mechanisms to resolve such conflicts. A comprehen-

sive approach to conflict management, rather than a
narrow focus only upon overt, uncompromising
predator decimation, is a valid and potentially more
sustainable strategy to manage human-wildlife
conflicts. Can targeting and controlling carnivore
proliferation resolve the dilemma and validate this
premise of alternative, nonpernicious intervention?
Historically, control of mammalian reproduction
has been primarily directed toward domestic companion animals and livestock. Contraception has typically
consisted either of surgical neutering of individuals,
hormonal manipulation of reproductive function, or
simple physical separation of the sexes. While the
neutering of feral cats has been suggested as an
alternative to elimination (Zaunbrecher and Smith
1993), these techniques, which are suited for management of individual reproductive function, may only
rarely be applicable to most free-ranging carnivore
populations, given the constraints of diverse species
distribution and abundance. In contrast, oral delivery
of a contraceptive agent for reproductive control
among wild carnivores may be more feasible; initial
efforts were reported as early as three decades ago
(Balser 1964).
The observation of naturally occurring antisperm
antibodies in a small proportion of humans has
generated interest in the recruitment of the immune
system for reproductive modulation (Aitken et al.
1993). Some postulated advantages of immunologically mediated contraception may be (1) economical
vaccine production by recombinant techniques,
(2) ease of administration, (3) relatively few side
effects, and (4) a higher degree of biological specificity
than traditional chemical drug delivery, which may
have a broader phylogenetic and physiological spectrum of activity. From an ecological perspective, one
potential advantage of wildlife immunocontraception
would be to minimize deleterious effects of freeranging carnivores by reducing or stabilizing total
numbers, while avoiding vacant niches inherent to
lethal reduction. A nonreproductive adult would inhibit
ingress of new, fully reproductive individuals from
surrounding areas (Porter et al. 1991). Arguably, one
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weakness of the immunocontraception prospectus is
individual variation in the immune response, which
may lead to unpredictability regarding the duration and
magnitude of effect in a particular animal. However, if
a measurable effect among a local population is
achieved, some variation among individuals may be
acceptable.
Typically, oocyte and sperm antigens are sufficiently compartmentalized so that an immune response is not normally elicited; however, these
antigens are clearly immunogenic (Haimovici et al.
1992, Liu et al. 1990). In this regard, considerable
research has focused on zona pellucida (ZP) antigens
(Kirkpatrick et al. 1991 and 1992, Hasegawa et al.
1992, Jones et al. 1992). Despite a highly speciesspecific interaction between the sperm surface and a
glycoprotein component of the ZP, antibodies to the
ova of one species inhibit in vitro and in vivo fertilization of another species (Aitken et al. 1993). An
unexpected finding from ZP immunization has been
the delayed cessation of ovarian cycling from destruction of primordial follicles or essentially induced
premature menopause in animal models (Hasegawa
et al. 1992, Jones et al. 1992), another potential
drawback in the implementation for wildlife.
Alternative approaches have focused upon
inducing antibodies to the cumulus oophorus of the
conceptus (Tesarik et al. 1990) or disrupting regulatory
hormones such as human chorionic gonadotrophin,
gonadotropin-releasing hormone, luteinizing hormonereleasing hormone, and follicle-stimulating hormone
(Aitken et al. 1993). Additionally, while still the subject
is still in the early stages of investigation, some
promising results have also been obtained with
disruption of spermatogenesis (Grubb 1991). Some of
these methods raise complex medical or ethical
issues, for human reproductive manipulation because
the end result may be essentially abortifacient or
complications related to immune-complex formation.
Whether these matters would be equally as controversial when applied to a "nuisance" carnivore species
has yet to be determined. However, it should be clear
that absolute restriction to the species of interest
would be optimal.

Other suggested interventions would target
levels of reproductive hormone (testosterone or
progesterone) directly (Linhart 1964, Linhart et al.
1968, Awoniyi et al. 1992, Moudgal et al. 1992, Talwar
et al. 1992, Vanage et al. 1992, Deshmukh et al. 1993,
Dowsett et al. 1993, Ladd 1993). The significant
limitation of this approach in a free-ranging carnivore
population is the potential for an undesirable effect
upon sexual behavior, social interactions, and hierarchy (Awoniyi et al. 1992, Moudgal et al. 1992, Dowsett
et al. 1993).
To date, no species-specific reproductive antigens
have been identified, although unique contraceptive
antigens for humans (Aitken et al. 1993), wolves (U.S.
Department of Agriculture 1992), red foxes, rabbits,
kangaroos (Morell 1993), deer (Porter et al. 1991), wild
swine (Fletcher et al. 1990), and many others (WynneEdwards 1964), would be of great utility. The apparent
conservation of many reproductive antigens among
mammalian groups raises the undesirable, even detrimental, potential to unintentionally affect nontarget
species, possibly including humans, valuable domestic
animals, endangered or threatened wildlife, and
nonnuisance carnivore species. In lieu of speciesspecific antigens, a species-specific vector (plasmid
DNA, viral, bacterial, etc.) would be a potential strategy
to limit the contraceptive effect solely to the target
species. Unfortunately, such carnivore species-specific
vectors have also yet to be identified.
The physical delivery of a desired contraceptive
may consist of a variety of singly applied or combined
approaches. For example, live-trapping of free-ranging
carnivores and direct inoculation of a contraceptive may
be of some value, particularly in areas where high
human<arnivore interaction is problematic and necessitates a response, but complete elimination of carnivores
is not desired by human residents, and lethal control is
unacceptable. Except for under these limited conditions,
the labor-intensive nature of this approach and the poor
capture rates of some carnivore species may render this
method largely impractical.
Conversely, injection of contraceptive agents may
be achieved remotely via a blow gun, dart gun, or similar
device. This is currently a procedure in progress for an
insular population of feral horses off the eastern mid-
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Table 1. O r a l v a c c i n a t i o n of c a r n i v o r e s with recombinant v i r u s e s
Agent

Species (common name)

Reference

Vaccinia-Rabies Glycoprotein Recombinant Virus
Family Canidae

Vuipes vuipes (red fox)
Canis iupus (domestic dog)
C. iatrans (coyote)
Aiopex iagopus (arctic fox)
Nyctereutes procyonoides (raccoon dog)
Urocyon cinereoargenteus (grey fox)

Biancou et al. (1986)
Blancou et al. (1989)
Artois et a . (1990)
Chappuis and Kovalev (1991)
Chappuis and Kovaev (1991)
Rupprecht el ai. (1992a)

Feiis domesticus (domestic cat)
Lynx rufus (bobcat)

~ l a n c o uet ai. (1989)
Rupprecht el ai. (1992a)

Mephitis mephitis (str~pedskunk)
Mustela putorius (ferret)
Meies meies (European badger)
Lutra canadensis (river otter)
Musteia vision (mlnk)

Toison et al. (1987)
Brocher el al. (1988)
Broch~eret al. (1989)
Rupprecht et a1 (1992a)
Rupprecht et al. (1992a)

Family Procyondae

Procyon iotor (raccoon)

Wklor et ai. (1985)

Family Ursidae

~ r s u i ~ r n e r i c a n u(biack
s
bear)

Rupprecht et al. (1992a)

~-

p~

Family Fel~dae
~-

Family Musteiidae

-

-

-

~

Raccoonpox-Rabies Glycoprotein Recombinant Virus
Family Procyonidae

P iofor

Famlly Canidae

C, lupus

Esposito et ai. (1988)
~

p~
~

~

Family Felidae
--

Family Mustelidae

--

~--

~

~spoiLtoet a1 (1992)

U, cinereoargenteus
F domesticus
L. rufus

~

~

~

~~~

M mephitis

Esposlto et al. (1992)
Esposto et al. (1992)
Esposito et al. (1992)
Fekadu etal. (1991)

Human Adeno(5)-Rabies Glycoprotein Recombinant Virus
Family Procyonidae

P iotor

Family Canidae

L! vuipes
C. lupus

Family Musteiidae

M. mephitis

~-~

-~

Charlton el a . (1992)~-

~

Chariton et al. (1992)
Campbell (1994)
~

Charlton et al. (1992)

Baculo-Rabies Glycoprotein Recombinant Virus
Family Procyonidae

P iotor

Atlantic shore (Kirkpatrick et al. 1991 and 1992). As
above, this approach is also largely limited by species
secretiveness, tolerance for humans, the accuracy of the
operator, and the ability to identify previously inoculated
individuals.
Given these limitations, additional methodologies
may have to be considered for long-term, widespread
carnivore reproductive control. For example, the effectiveness and relative ease of using baits to deliver a
biological, rather than lethal chemicals as practiced
historically, to wild carnivores has been demonstrated,
principally through the wildlife rabies vaccination of
several reservoir species in Europe and North America

Fu et ai. (1993)

(Johnston et al. 1988, Bachmann et al. 1990, Brochier et
al. 1990, Rupprecht et al. 1992a, Winkler and Bogel
1992, Campbell 1994). This example of wildlife rabies
vaccination has often been cited over the last decade to
document the degree of sophistication achieved in
reaching free-ranging carnivore populations. To date,
these field systems involve either modified live rabies
viruses or recombinant orthopoxvirus vectors that
undergo limited replication without perpetuation or
apparent adverse effect (at least in the latter viral
scenerio) in the targeted host. The advantages of a selfreplicating entity are economy and the more reliable
induction of an immune response without the need for
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multiple doses or adjuvants. Moreover, vectors with wide
carnivore host susceptibility (table 1) are advantageous
with a disease such as rabies, in which the pathogen
is not restricted to a single narrow host niche. For
example, a single biologic may be useful for control of
rabies in raccoons, red foxes, and coyotes in various
geographic areas where rabies strains are perpetuated by different carnivore species. Yet this same
precept of broad application may be counterproductive
without species-specific expression products, when
the effect is immunocontraception in co-occurring
species, rather than simply rabies vaccination.
In addition to live virus vaccination, successful
oral immunization of raccoons in captivity has also
been demonstrated with a baculo-virus system, in
which rabies glycoprotein expression in an insect cell
culture resulted in sufficient quantities of antigen to
immunize animals directly by mouth (Fu et al. 1993).
Similarly, raccoons and other carnivores may be orally
immunized with inactivated viral preparations
(Rupprecht et al. 1992b). While the amount of antigen
required may be economically prohibitive given current
production limitations, the concept offers a choice
avenue of investigation that departs from the traditionalist approach toward a replicative vector, if a restricted reproductive antigen were available.
A self-replicating biologic has an inherent potential for adverse effects that is influenced by host
variables, such as species and individual age, immune
status, concurrent infectious or metabolic conditions,
etc. The latent risk for adverse effects may be nearly
immeasurable under traditional laboratory or field
conditions. These concerns are particularly relevant
to an immunocontraceptive, self-replicating biologic
destined for free-choice broadcasting and consumption. While the occurrence of immunocompromised
hosts at risk for vaccine exposure may be remote, any
self-replicating vector, even a highly attenuated virus,
presents increased risks in such a host (Fenner et al.
1988, Hierholzer 1992).
The immunocompromised host scenerio has led
to the development of functional animal models.
Bosma and Carroll (1991) have identified a single
gene mutation in mice that results in the inability to
form functional B and T cells in homozygotes. Lacking

the capacity for a specific immune response to pathogens and commensal organisms alike, severe combined immunodeficient (SCID) mice must be housed
under aseptic conditions in a pathogen-free environment. An inheritable, functionally similar condition
occurs in humans. Thus, the SCID model may be
particularly useful in the elucidation of events during
recombinant viral infection and may contribute toward
the knowledge of the overall biosafety of these new
biologics (Hanlon et al. 1997). Additionally, such
studies may identify critical components of a prophylactic regimen, should adverse effects occur in an
immunocompromised host. As a more sophisticated
working knowledge of viral genetics is gained, genomic sequences crucial for replication in a particular
host may be targeted and eliminated (Tartaglia et al.
1992a and b), increasing species specificity, as well as
overall biological safety.
The synergism provided by vaccine vector, bait
type, and distribution parameters (density, method,
spatiotemporal factors) should ultimately maximize
target species contact and minimize nontarget species
uptake of a given biological. However, it is difficult to
imagine total vaccine restriction to a single carnivore
population even under ideal circumstances. Many bait
studies have previously demonstrated an effect on
species other than the target and implications for
nontarget groups, such as domestic animals, humans
and nonmammals, despite the original application and
intention (Ballantyne and O'Donoghue 1954, Linhart
1964, Lewis 1968, Westergaard 1982, Bachmann et
al. 1990, Fletcher et al. 1990, Trewhella et al. 1991).
For example, a decade of applied research toward
development of a prototype delivery device for oral
raccoon rabies vaccination (Rupprecht et al. 1987) in
the Eastern United States, resulted in a fishmealpolymer bait that was readily consumed by a majority
of raccoons under laboratory and field conditions
(Rupprecht et al. 1992a). Yet variations in bait density
(10-100/ha), distribution season, habitat type (barrier
island to forested uplands), or method (hand delivery
v. aerial), targeting ecotones suggestive of high
raccoon activity, were unable to exclude consumption
by other mammals (Hanlon et al. 1989 and 1993,
Hable et al. 1992, Rupprecht et al. 1992a). Viewed as
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Table 2. Biomarker' detection in nontarget species from
fishmeal-polymer bait consumption: Virginia, Pennsylvania, and New Jersey (1990-93)
Species

NO. positiveitotal

Percent

O~ossum(Didelohis viroinianusl
"

64195

67

Striped skunk (Mephitis mephitis)

13132

41

Domestic cat lFelis domesficus)

6/20

30

Red fox (Vulpes vulpes)

216

33

Rwer otter (Luira canadensis)

115

20

Porcup~ne(Erythizon dorsafum)

3/36

8

Black bear (Ursus amencanus)

211 98

1

Norway rat- (Raitus norvegicus)
-

118

13

--

House mouse (Mus musculus)
Rice rat (Oryzomys palusfris)
'Tetracycline analysts from mandibular bone as described by Hanlon el a1
(1 989).

a composite (table 2), utilization in excess of 100,000
V-RG vaccine-laden baits specifically for raccoons
nevertheless demonstrated contact by a variety of
other carnivores and a few rodent species (albeit
extremely small numbers). Overall biomarker data
indicated bait consumption by a limited variety and
number of nontarget species with no evidence of
consumption by certain others (such as white-tailed
deer during hunting season). These results could not
have been predicted a priori, without placebo baiting
and nontarget species surveillance. Observed nontarget species outcomes from vaccine exposure in the
field have ranged from no apparent effect to immunization. However, what does the bait contact rate of a
nontarget, competitor species (e.g., opossums) imply,
especially if it approximates or exceeds that of the
target species [raccoons]? From a disease control
perspective, in which no untoward effects have been
demonstrated in the nontarget species at issue, the
answer may range from simple nuisance to a resultant
economic infeasibility, depending upon the degree of
interference and the number of vaccine-laden baits not
available to the intended species. Clearly, what looks
like a trifling matter-say, an overabundance of
opossums vaccinated against a given infectious
disease-may not be trivial in regard to immunocontraception, in light of species-specific vectors,

antigens, baits, etc. This nontarget species contact
problem may figure prominently if the species in
question is a keystone species.
Long-term results of applying free-choice oral
immunocontraception to free-ranging carnivores (and
the associated nontarget milieu) are impossible to
predict at present with any reasonable degree of
certainty, as regards either safety or efficacy. For
example, the efficacy of oral rabies vaccination among
a target population may be assessed by (1) confinement studies with baits followed by challenges,
(2) capture of free-ranging animals from a vaccinated
area for subsequent laboratory challenge (Rupprecht
et al. 1993), (3) measurement of seroconversion
among free-ranging animals in an area, or simply
(4) surveillance for naturally occurring disease.
However, the minimal acceptable levels of these
assessment techniques that would predict successful
disease control or elimination are not known a priori,
nor from present data, nor for a variety of complex
ecological settings.
A proportion of the population may not consume
baits due to a variety of factors. Some heritable
behavioral traits, such as temerity in consumption or
total avoidance of novel items, like artificial baits, may
play a role in the inability to reach a segment of the
targeted population. It follows that a particular cohort
with a behavioral trait of bait avoidance may gain a
competitive advantage. The result would be increasing difficulty in reaching this remaining, actively
prepetuating segment of the population via baits. This
scenario may be particularly troublesome given the
high reproductive capacity of some species. Additionally, because no vaccine is completely efficacious in
all individuals, it may be possible to selectively favor
nonresponders (the perceived "mangey" or "wormy"
individuals), due to major histocompatibility restriction,
inherited immunodeficiencies,or immunocompromising
infectious agents (Nossal 1989). If these latter
theoretical demes gain even a minor reproductive
advantage within a population, they may eventually
initiate or exacerbate disease and related conditions.
Amplification of this particular component of a carnivore population may severely restrict genetic diversity,
as in present day cheetah (i.e., Acinonyx) (Cohn
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1986), and subsequently compromise the overall
health and viability of the community at large.
TO be ultimately successful, an immunocontraceptive control program will intuitively require reaching
a majority of individuals; how can the ideal mix of
gene frequencies be ensured in light of this seeming
conundrum? At first consideration, a readily transmissible, "safe" recombinant agent (while a bane to
regulatory authorities) might appear to overcome the
limitation of inequitable bait uptake and biological
response. Exposure to a readily transmissible vector
could approach unity, successfully reaching all members of a particular carnivore population. But, as
evidenced by the global emergence and entrenchment
of canine parvovirus within domestic and wild canid
populations (Parrish 1994), this strategy may have
significant uncontrollable and potentially detrimental
effects. Even if a so-called species-specific antigen
were discovered, geographic containment of such a
highly contagious agent could not be assured. How
would programs aimed, for example, at red foxes in
the New World prevent exchange to red foxes in the
Old World, involvement of related subspecies, or
spillover to kin in the same genus, given the frequency
of transoceanic travel and exotic and endemic species
translocations (Rupprecht et al. 1996)? Similar
questions could be raised for other taxa-canid,
mustelid, viverrid, etc.
In conclusion, incipient investigations toward
immunocontraceptive population management are
quite intriguing. Their development for free-ranging
carnivores appears well motivated and potentially
desirable, at first glance, for numerous applications,
given the limitations of available alternatives to
reconcile the human-predator interface problem.
Nonetheless, it will be crucial to proceed from the
outset in as prudent a manner as possible, given the
above-voiced concerns. It will be necessary to
address, in comprehensive fashion, the potential for
untoward events, and objectively divest real from
perceived risks, much akin to the scientific scrutiny
directed toward recombinant biologics more than a
decade ago. In concordance with the recommendations of the World Health Organization (1993) in their
Consultation on Reproductive Control of Carnivores,

future directions of immunocontraceptive research
should include continued efforts to develop speciesspecific bait delivery techniques, and species-specific
contraceptive effects, either through antigen or vector.
Given these goals, future research would logically
involve international, multidisciplinary, collaborative
efforts, strongly based upon objective, testable
hypotheses. Until then, free-choice broadcasting of
nonrestrictive contraceptive biologics may be unconscionable due to, as yet, unpredictable, undesirable,
and potentially far-reaching repercussions, not only in
the target species, but also in critical nontargets that
share this increasingly burdened and now readily
traversed globe.
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